“Risk of de novo or secondary cancer after solid organ or allogeneic haematopoietic stem cell transplantation”

ConclusionRates of de novo or secondary cancers are elevated in both SOT and HSCT compared with the general population and mainly for skin and haematological cancers. Among transplant recipients, older age and current elevated CRP are risk factors.

Source: Journal of Cancer Research and Clinical Oncology - October 4, 2019 Category: Cancer & Oncology Source Type: research